Evangelos Stavropoulos

3.2k total citations
22 papers, 2.4k citations indexed

About

Evangelos Stavropoulos is a scholar working on Infectious Diseases, Immunology and Epidemiology. According to data from OpenAlex, Evangelos Stavropoulos has authored 22 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Infectious Diseases, 17 papers in Immunology and 12 papers in Epidemiology. Recurrent topics in Evangelos Stavropoulos's work include Tuberculosis Research and Epidemiology (17 papers), Mycobacterium research and diagnosis (12 papers) and Immune Response and Inflammation (4 papers). Evangelos Stavropoulos is often cited by papers focused on Tuberculosis Research and Epidemiology (17 papers), Mycobacterium research and diagnosis (12 papers) and Immune Response and Inflammation (4 papers). Evangelos Stavropoulos collaborates with scholars based in United Kingdom, United States and Tanzania. Evangelos Stavropoulos's co-authors include Ricardo E. Tascon, M. Joseph Colston, Douglas B. Lowrie, Silvia Ragno, Anne O’Garra, Paul S. Redford, M J Colston, Katalin Lukács, R. Glyn Hewinson and Jonathan M. Pitt and has published in prestigious journals such as Nature, Nature Medicine and Nature Communications.

In The Last Decade

Evangelos Stavropoulos

21 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Evangelos Stavropoulos United Kingdom	19	1.6k	1.2k	1.2k	591	290	22	2.4k
Alexander Apt Russia	29	1.6k 1.0×	1.3k 1.1×	993 0.8×	584 1.0×	315 1.1×	112	2.5k
Angelo Izzo United States	28	2.3k 1.4×	1.4k 1.2×	1.6k 1.4×	895 1.5×	404 1.4×	70	3.3k
Pawan Sharma India	28	1.2k 0.7×	939 0.8×	791 0.7×	721 1.2×	247 0.9×	86	2.3k
Nathalie Winter France	33	1.6k 1.0×	1.3k 1.1×	1.6k 1.4×	699 1.2×	262 0.9×	72	3.4k
Steven C. Derrick United States	24	2.4k 1.5×	1.5k 1.3×	1.5k 1.2×	808 1.4×	398 1.4×	42	3.2k
Ricardo E. Tascon United Kingdom	22	1.3k 0.8×	1.0k 0.8×	1.4k 1.2×	900 1.5×	177 0.6×	31	2.6k
Nacho Aguiló Spain	31	1.4k 0.8×	813 0.7×	1.4k 1.2×	694 1.2×	198 0.7×	73	2.5k
M. Lagranderie France	27	1.1k 0.7×	1.0k 0.9×	1.3k 1.1×	427 0.7×	219 0.8×	47	2.3k
Susan L. Baldwin United States	28	1.8k 1.1×	1.5k 1.2×	1.7k 1.4×	824 1.4×	172 0.6×	65	3.1k
Ana Paula Junqueira‐Kipnis Brazil	26	981 0.6×	744 0.6×	881 0.7×	416 0.7×	194 0.7×	99	1.9k

Countries citing papers authored by Evangelos Stavropoulos

Since Specialization

Citations

This map shows the geographic impact of Evangelos Stavropoulos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evangelos Stavropoulos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evangelos Stavropoulos more than expected).

Fields of papers citing papers by Evangelos Stavropoulos

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Evangelos Stavropoulos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evangelos Stavropoulos. The network helps show where Evangelos Stavropoulos may publish in the future.

Co-authorship network of co-authors of Evangelos Stavropoulos

This figure shows the co-authorship network connecting the top 25 collaborators of Evangelos Stavropoulos. A scholar is included among the top collaborators of Evangelos Stavropoulos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Evangelos Stavropoulos. Evangelos Stavropoulos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Branchett, William J., Evangelos Stavropoulos, Lúcia Moreira-Teixeira, et al.. (2025). Type I IFN drives neutrophil swarming, impeding lung T cell–macrophage interactions and TB control. The Journal of Experimental Medicine. 222(12).

Moreira-Teixeira, Lúcia, Evangelos Stavropoulos, Sabelo Hadebe, et al.. (2020). Type I IFN exacerbates disease in tuberculosis-susceptible mice by inducing neutrophil-mediated lung inflammation and NETosis. Nature Communications. 11(1). 5566–5566. 130 indexed citations

Moreira-Teixeira, Lúcia, Olivier Tabone, Christine M. Graham, et al.. (2020). Mouse transcriptome reveals potential signatures of protection and pathogenesis in human tuberculosis. Nature Immunology. 21(4). 464–476. 76 indexed citations

Moreira-Teixeira, Lúcia, Paul S. Redford, Evangelos Stavropoulos, et al.. (2017). T Cell–Derived IL-10 Impairs Host Resistance to Mycobacterium tuberculosis Infection. The Journal of Immunology. 199(2). 613–623. 91 indexed citations

Pitt, Jonathan M., Simon Blankley, Krzysztof Potempa, et al.. (2016). Analysis of Transcriptional Signatures in Response to Listeria monocytogenes Infection Reveals Temporal Changes That Result from Type I Interferon Signaling. PLoS ONE. 11(2). e0150251–e0150251. 4 indexed citations

McNab, Finlay W., Ricardo Rajsbaum, Evangelos Stavropoulos, et al.. (2013). TPL-2–ERK1/2 Signaling Promotes Host Resistance against Intracellular Bacterial Infection by Negative Regulation of Type I IFN Production. The Journal of Immunology. 191(4). 1732–1743. 74 indexed citations

Redford, Paul S., Katrin D. Mayer-Barber, Finlay W. McNab, et al.. (2013). Influenza A Virus Impairs Control of Mycobacterium tuberculosis Coinfection Through a Type I Interferon Receptor–Dependent Pathway. The Journal of Infectious Diseases. 209(2). 270–274. 107 indexed citations

Redford, Paul S., André Boonstra, Simon Read, et al.. (2010). Enhanced protection to Mycobacterium tuberculosis infection in IL‐10‐deficient mice is accompanied by early and enhanced Th1 responses in the lung. European Journal of Immunology. 40(8). 2200–2210. 194 indexed citations

Stavropoulos, Evangelos, et al.. (2010). Synthesis and in vivo biological activity of large-ringed calixarenes against Mycobacterium tuberculosis. Tetrahedron. 67(2). 373–382. 18 indexed citations

10.

Roy, Edward J., Aruna Dharshan De Silva, Vasan K. Sambandamurthy, et al.. (2005). Induction of high levels of protective immunity in mice after vaccination using dendritic cells infected with auxotrophic mutants of Mycobacterium tuberculosis. Immunology Letters. 103(2). 196–199. 3 indexed citations

11.

Stavropoulos, Evangelos, John J. Brennan, S. B. Coade, et al.. (2005). Therapeutic Efficacy of High-Dose Intravenous Immunoglobulin inMycobacterium tuberculosisInfection in Mice. Infection and Immunity. 73(9). 6101–6109. 73 indexed citations

12.

Xue, Tian, Evangelos Stavropoulos, Min Yang, et al.. (2004). RNA Encoding the MPT83 Antigen Induces Protective Immune Responses againstMycobacterium tuberculosisInfection. Infection and Immunity. 72(11). 6324–6329. 53 indexed citations

13.

Ferraz, José Cândido, Evangelos Stavropoulos, Min Yang, et al.. (2004). A Heterologous DNA Priming- Mycobacterium bovis BCG Boosting Immunization Strategy Using Mycobacterial Hsp70, Hsp65, and Apa Antigens Improves Protection against Tuberculosis in Mice. Infection and Immunity. 72(12). 6945–6950. 65 indexed citations

14.

Colston, M. Joseph, et al.. (2004). Antimycobacterial Calixarenes Enhance Innate Defense Mechanisms in Murine Macrophages and Induce Control ofMycobacterium tuberculosisInfection in Mice. Infection and Immunity. 72(11). 6318–6323. 39 indexed citations

15.

Tascon, Ricardo E., et al.. (2000). Mycobacterium tuberculosis‐activated dendritic cells induce protective immunityin mice. Immunology. 99(3). 473–480. 99 indexed citations

16.

Brosch, Roland, W. Philipp, Evangelos Stavropoulos, et al.. (1999). Genomic Analysis Reveals Variation between Mycobacterium tuberculosis H37Rv and the Attenuated M. tuberculosis H37Ra Strain. Infection and Immunity. 67(11). 5768–5774. 121 indexed citations

17.

Lowrie, Douglas B., Ricardo E. Tascon, Vânia Luiza Deperon Bonato, et al.. (1999). Therapy of tuberculosis in mice by DNA vaccination. Nature. 400(6741). 269–271. 391 indexed citations

18.

Tascon, Ricardo E., Evangelos Stavropoulos, Katalin Lukács, & M. Joseph Colston. (1998). Protection againstMycobacterium tuberculosisInfection by CD8⁺T Cells Requires the Production of Gamma Interferon. Infection and Immunity. 66(2). 830–834. 194 indexed citations

19.

Heym, Béate, Evangelos Stavropoulos, Nadine Honoré, et al.. (1997). Effects of overexpression of the alkyl hydroperoxide reductase AhpC on the virulence and isoniazid resistance of Mycobacterium tuberculosis. Infection and Immunity. 65(4). 1395–1401. 102 indexed citations

20.

Tascon, Ricardo E., et al.. (1996). Vaccination against tuberculosis by DNA injection. Nature Medicine. 2(8). 888–892. 425 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact